糖尿病性網膜症治療の世界市場

◆英語タイトル:Diabetic Retinopathy Treatment - Global Market Outlook (2015-2022)
◆商品コード:SMRC65064
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:141
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥460,650見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥582,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、糖尿病性網膜症治療の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・糖尿病性網膜症治療の世界市場:治療種類別分析/市場規模
・糖尿病性網膜症治療の世界市場:疾患種類別分析/市場規模
・糖尿病性網膜症治療の世界市場:需要先別分析/市場規模
・糖尿病性網膜症治療の世界市場:地域別分析/市場規模
・糖尿病性網膜症治療のアメリカ市場規模予測
・糖尿病性網膜症治療のヨーロッパ市場規模予測
・糖尿病性網膜症治療のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Diabetic Retinopathy Treatment market is expected to reach $10.24 billion by 2022. Rising prevalence of diabetics, increasing management financial support, change in lifestyle and global aging population are the factors driving the market growth. However, Lack of accurate diagnosis, a lack of skilled ophthalmologist coupled with poor infrastructure and extended approval time for drugs are hampering the growth of global diabetic retinopathy market. Increase in awareness of diabetic retinopathy treatment and improvement of patient monitoring are some of the major trends in the market. The two main stages of diabetic retinopathy are non-proliferated and proliferated. Proliferated diabetic retinopathy is the mainly insecure stage and has the risk of detachment into the vitreous leading to severe vision loss.
North America leads the global diabetic retinopathy market due to vast number of aging population. The Asia Pacific diabetic retinopathy market is expected to witness profitable growth over the estimated period due to the occurrence of unmet needs in the developing countries such as China and India. These countries are expected to be the fastest growing diabetic retinopathy markets in Asia-Pacific region.

Some of the key players in the market include Regeneron Pharmaceuticals Inc., ThromboGenics, Genentech, Bayer Healthcare, Alimera Sciences, Actavis PLC, BCN Peptides, Novartis AG, Ampio Pharmaceuticals, Kowa Group, Sirnaomics Incorporation, Abbott Laboratories Ltd, Glycadia Pharmaceuticals, Alcon Laboratories Inc. and Parexel International Corp.

Type of Treatments Covered:
• Intraocular Steroid Injection
• Vitrectomy
• Anti-Vascular Endothelial Growth Factor (VEGF) drug
• Laser Surgery

Disease Type Covered:
• Proliferative Diabetic Retinopathy (PDR)
• Non-Proliferative Diabetic Retinopathy (NPDR)
o Moderate
o Mild
o Severe

End Users Covered:
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Hospitals
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Diabetic Retinopathy Treatment Market, By Treatment type
5.1 Introduction
5.2 Intraocular Steroid Injection
5.3 Vitrectomy
5.4 Anti-Vascular Endothelial Growth Factor (VEGF) drug
5.5 Laser Surgery

6 Global Diabetic Retinopathy Treatment Market, By Disease Type
6.1 Introduction
6.2 Proliferative Diabetic Retinopathy (PDR)
6.3 Non-Proliferative Diabetic Retinopathy (NPDR)
6.3.1 Moderate
6.3.2 Mild
6.3.3 Severe

7 Global Diabetic Retinopathy Treatment Market, By End User
7.1 Introduction
7.2 Ophthalmic Clinics
7.3 Ambulatory Surgical Centers
7.4 Hospitals
7.5 Other End Users

8 Global Diabetic Retinopathy Treatment Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Regeneron Pharmaceuticals Inc.
10.2 ThromboGenics
10.3 Genentech
10.4 Bayer Healthcare
10.5 Alimera Sciences
10.6 Actavis PLC
10.7 BCN Peptides
10.8 Novartis AG
10.9 Ampio Pharmaceuticals
10.10 Kowa Group
10.11 Sirnaomics Incorporation
10.12 Abbott Laboratories Ltd
10.13 Glycadia Pharmaceuticals
10.14 Alcon Laboratories Inc.
10.15 Parexel International Corp.
List of Tables
Table 1 Global Diabetic Retinopathy Treatment Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Diabetic Retinopathy Treatment Market Outlook, By Treatment type (2013-2022) ($MN)
Table 3 Global Diabetic Retinopathy Treatment Market Outlook, By Intraocular Steroid Injection (2013-2022) ($MN)
Table 4 Global Diabetic Retinopathy Treatment Market Outlook, By Vitrectomy (2013-2022) ($MN)
Table 5 Global Diabetic Retinopathy Treatment Market Outlook, By Anti-Vascular Endothelial Growth Factor (VEGF) drug (2013-2022) ($MN)
Table 6 Global Diabetic Retinopathy Treatment Market Outlook, By Laser Surgery (2013-2022) ($MN)
Table 7 Global Diabetic Retinopathy Treatment Market Outlook, By Disease Type (2013-2022) ($MN)
Table 8 Global Diabetic Retinopathy Treatment Market Outlook, By Proliferative Diabetic Retinopathy (PDR) (2013-2022) ($MN)
Table 9 Global Diabetic Retinopathy Treatment Market Outlook, By Non-Proliferative Diabetic Retinopathy (NPDR) (2013-2022) ($MN)
Table 10 Global Diabetic Retinopathy Treatment Market Outlook, By Moderate (2013-2022) ($MN)
Table 11 Global Diabetic Retinopathy Treatment Market Outlook, By Mild (2013-2022) ($MN)
Table 12 Global Diabetic Retinopathy Treatment Market Outlook, By Severe (2013-2022) ($MN)
Table 13 Global Diabetic Retinopathy Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 14 Global Diabetic Retinopathy Treatment Market Outlook, By Ophthalmic Clinics (2013-2022) ($MN)
Table 15 Global Diabetic Retinopathy Treatment Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 16 Global Diabetic Retinopathy Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 17 Global Diabetic Retinopathy Treatment Market Outlook, By Other End Users (2013-2022) ($MN)
Table 18 North America Diabetic Retinopathy Treatment Market Outlook, By Treatment type (2013-2022) ($MN)
Table 19 North America Diabetic Retinopathy Treatment Market Outlook, By Intraocular Steroid Injection (2013-2022) ($MN)
Table 20 North America Diabetic Retinopathy Treatment Market Outlook, By Vitrectomy (2013-2022) ($MN)
Table 21 North America Diabetic Retinopathy Treatment Market Outlook, By Anti-Vascular Endothelial Growth Factor (VEGF) drug (2013-2022) ($MN)
Table 22 North America Diabetic Retinopathy Treatment Market Outlook, By Laser Surgery (2013-2022) ($MN)
Table 23 North America Diabetic Retinopathy Treatment Market Outlook, By Disease Type (2013-2022) ($MN)
Table 24 North America Diabetic Retinopathy Treatment Market Outlook, By Proliferative Diabetic Retinopathy (PDR) (2013-2022) ($MN)
Table 25 North America Diabetic Retinopathy Treatment Market Outlook, By Non-Proliferative Diabetic Retinopathy (NPDR) (2013-2022) ($MN)
Table 26 North America Diabetic Retinopathy Treatment Market Outlook, By Moderate (2013-2022) ($MN)
Table 27 North America Diabetic Retinopathy Treatment Market Outlook, By Mild (2013-2022) ($MN)
Table 28 North America Diabetic Retinopathy Treatment Market Outlook, By Severe (2013-2022) ($MN)
Table 29 North America Diabetic Retinopathy Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 30 North America Diabetic Retinopathy Treatment Market Outlook, By Ophthalmic Clinics (2013-2022) ($MN)
Table 31 North America Diabetic Retinopathy Treatment Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 32 North America Diabetic Retinopathy Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 33 North America Diabetic Retinopathy Treatment Market Outlook, By Other End Users (2013-2022) ($MN)
Table 34 Europe Diabetic Retinopathy Treatment Market Outlook, By Treatment type (2013-2022) ($MN)
Table 35 Europe Diabetic Retinopathy Treatment Market Outlook, By Intraocular Steroid Injection (2013-2022) ($MN)
Table 36 Europe Diabetic Retinopathy Treatment Market Outlook, By Vitrectomy (2013-2022) ($MN)
Table 37 Europe Diabetic Retinopathy Treatment Market Outlook, By Anti-Vascular Endothelial Growth Factor (VEGF) drug (2013-2022) ($MN)
Table 38 Europe Diabetic Retinopathy Treatment Market Outlook, By Laser Surgery (2013-2022) ($MN)
Table 39 Europe Diabetic Retinopathy Treatment Market Outlook, By Disease Type (2013-2022) ($MN)
Table 40 Europe Diabetic Retinopathy Treatment Market Outlook, By Proliferative Diabetic Retinopathy (PDR) (2013-2022) ($MN)
Table 41 Europe Diabetic Retinopathy Treatment Market Outlook, By Non-Proliferative Diabetic Retinopathy (NPDR) (2013-2022) ($MN)
Table 42 Europe Diabetic Retinopathy Treatment Market Outlook, By Moderate (2013-2022) ($MN)
Table 43 Europe Diabetic Retinopathy Treatment Market Outlook, By Mild (2013-2022) ($MN)
Table 44 Europe Diabetic Retinopathy Treatment Market Outlook, By Severe (2013-2022) ($MN)
Table 45 Europe Diabetic Retinopathy Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 46 Europe Diabetic Retinopathy Treatment Market Outlook, By Ophthalmic Clinics (2013-2022) ($MN)
Table 47 Europe Diabetic Retinopathy Treatment Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 48 Europe Diabetic Retinopathy Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 49 Europe Diabetic Retinopathy Treatment Market Outlook, By Other End Users (2013-2022) ($MN)
Table 50 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Treatment type (2013-2022) ($MN)
Table 51 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Intraocular Steroid Injection (2013-2022) ($MN)
Table 52 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Vitrectomy (2013-2022) ($MN)
Table 53 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Anti-Vascular Endothelial Growth Factor (VEGF) drug (2013-2022) ($MN)
Table 54 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Laser Surgery (2013-2022) ($MN)
Table 55 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Disease Type (2013-2022) ($MN)
Table 56 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Proliferative Diabetic Retinopathy (PDR) (2013-2022) ($MN)
Table 57 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Non-Proliferative Diabetic Retinopathy (NPDR) (2013-2022) ($MN)
Table 58 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Moderate (2013-2022) ($MN)
Table 59 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Mild (2013-2022) ($MN)
Table 60 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Severe (2013-2022) ($MN)
Table 61 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 62 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Ophthalmic Clinics (2013-2022) ($MN)
Table 63 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 64 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 65 Asia Pacific Diabetic Retinopathy Treatment Market Outlook, By Other End Users (2013-2022) ($MN)
Table 66 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Treatment type (2013-2022) ($MN)
Table 67 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Intraocular Steroid Injection (2013-2022) ($MN)
Table 68 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Vitrectomy (2013-2022) ($MN)
Table 69 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Anti-Vascular Endothelial Growth Factor (VEGF) drug (2013-2022) ($MN)
Table 70 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Laser Surgery (2013-2022) ($MN)
Table 71 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Disease Type (2013-2022) ($MN)
Table 72 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Proliferative Diabetic Retinopathy (PDR) (2013-2022) ($MN)
Table 73 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Non-Proliferative Diabetic Retinopathy (NPDR) (2013-2022) ($MN)
Table 74 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Moderate (2013-2022) ($MN)
Table 75 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Mild (2013-2022) ($MN)
Table 76 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Severe (2013-2022) ($MN)
Table 77 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By End User (2013-2022) ($MN)
Table 78 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Ophthalmic Clinics (2013-2022) ($MN)
Table 79 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 80 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
Table 81 Rest of the World Diabetic Retinopathy Treatment Market Outlook, By Other End Users (2013-2022) ($MN)



【レポートのキーワード】

糖尿病性網膜症、増殖糖尿病網膜症、糖尿病性網膜症治療、 治療薬、硝子体切除術、医薬品

★調査レポート[糖尿病性網膜症治療の世界市場]販売に関する免責事項
★調査レポート[糖尿病性網膜症治療の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆